KAREN INZIRILLO: Open Payments
NPI 1548968993 · BOCA RATON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,601 in 87 payments from 19 companies in 2025. Trend: 2023 $1,525 · 2024 $3,262 · 2025 $2,601
Food & beverage: $2,601
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $402 |
| ARGENX US, INC. | 8 | $394 |
| UCB, Inc. | 10 | $366 |
| Alexion Pharmaceuticals, Inc. | 6 | $349 |
| ACADIA Pharmaceuticals Inc | 11 | $216 |
| ABBVIE INC. | 8 | $177 |
| Lilly USA, LLC | 7 | $158 |
| Otsuka America Pharmaceutical, Inc. | 4 | $107 |
| PFIZER INC. | 4 | $106 |
| Teva Pharmaceuticals USA, Inc. | 4 | $80 |
Products named: HYQVIA, ULTOMIRIS, NUPLAZID, Zilbrysq, Rystiggo, VYVGART HYTRULO, VYVGART, KISUNLA.
Industry payments across FL — which companies pay providers there.
